SANUWAVE CEO granted 5,524 stock options at $10

SANUWAVE Health, Inc. reported that Chief Executive Officer C. Frank Morgan received a grant of stock options covering 5,524 shares of common stock.

Accepted by SEC EDGAR 07/02/2026 - 04:11 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

SANUWAVE Health, Inc. reported that Chief Executive Officer C. Frank Morgan received a grant of stock options covering 5,524 shares of common stock. The options have an exercise price of $10.0000 per share and expire on June 30, 2031. The filing states these options were fully vested on the grant date, and following this award he holds options for 5,524 underlying shares directly.

Insider Trade Summary

Grant/Award: 5,524 shares

Grant/Award 1 txn

Insider FRANK MORGAN C.

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	5,524	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 5,524 contracts (Direct)

Holdings Before and After: Stock Option (right to buy), 0 to 5,524 contracts (Direct)

Footnotes (1)

F1. Options were fully vested at the grant date.

Key Figures

Options granted: 5,524 options Exercise price: $10.0000 per share Expiration date: June 30, 2031 +2 more

5 metrics

Options granted 5,524 options Stock Option (right to buy) granted to CEO on June 30, 2026

Exercise price $10.0000 per share Strike price for CEO stock options

Expiration date June 30, 2031 Option term end for CEO grant

Underlying shares 5,524 shares Common stock underlying granted options

Post-grant option holdings 5,524 options Total options held following transaction

Key Terms

Stock Option (right to buy), Chief Executive Officer, exercise price, fully vested

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Chief Executive Officer financial

"officer_title: "Chief Executive Officer""

A chief executive officer (CEO) is the top leader of a company, responsible for making major decisions, setting goals, and guiding the organization’s overall direction. Think of the CEO as the captain of a ship, steering it toward success. Investors pay close attention to the CEO because their leadership and strategy can significantly influence the company's performance and future growth.

exercise price financial

"conversion_or_exercise_price: "10.0000""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested financial

"Options were fully vested at the grant date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SANUWAVE Health (SNWV) report for its CEO?

SANUWAVE Health reported that CEO C. Frank Morgan received a grant of 5,524 stock options. These options give him the right to buy common shares at a set price and represent equity-based compensation directly tied to the company’s stock performance.

How many SANUWAVE Health (SNWV) shares are covered by the new CEO option grant?

The new option grant to SANUWAVE Health’s CEO covers 5,524 underlying shares of common stock. Each option corresponds to one share, so exercising all options would allow purchase of 5,524 shares at the specified exercise price.

What is the exercise price and term of the CEO’s new SANUWAVE Health (SNWV) options?

The CEO’s new options have an exercise price of $10.0000 per share and expire on June 30, 2031. This means he can choose to buy shares at $10.0000 any time before the stated expiration date, subject to applicable conditions.

Were the new SANUWAVE Health (SNWV) CEO stock options vested immediately?

Yes. The filing notes that the options granted to SANUWAVE Health’s CEO were fully vested at the grant date. Full vesting means he does not need to meet additional service or performance conditions before being able to exercise these options.

How many SANUWAVE Health (SNWV) option shares does the CEO hold after this grant?

Following the grant, the CEO is reported to hold stock options for 5,524 underlying common shares directly. This figure reflects the total derivative holdings from this award shown in the filing’s post-transaction balance information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANK MORGAN C.

(Last)

(First)

(Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$10	06/30/2026		A		5,524		⁽¹⁾	06/30/2031	Common Stock	5,524	$0	5,524	D

Explanation of Responses:

1. Options were fully vested at the grant date.

	/s/ Griffin D. Foster, Attorney-in-Fact for Morgan C. Frank	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR